Sheng, W., Jiang, H., Wu, D., & Zheng, J. (2013). Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer. Associação Brasileira de Divulgação Científica.
Chicago Style aipamenaSheng, W.J., H. Jiang, D.L Wu, and J.H Zheng. Early Responses of the STAT3 Pathway to Platinum Drugs Are Associated With Cisplatin Resistance in Epithelial Ovarian Cancer. Associação Brasileira de Divulgação Científica, 2013.
MLA aipamenaSheng, W.J., H. Jiang, D.L Wu, and J.H Zheng. Early Responses of the STAT3 Pathway to Platinum Drugs Are Associated With Cisplatin Resistance in Epithelial Ovarian Cancer. Associação Brasileira de Divulgação Científica, 2013.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.